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Interferon Regulatory Factor-1 Is Required
for a T Helper 1 Immune Response In Vivo
Michael Lohoff,*²§ David Ferrick,*³§ disruption of the IRF-1 gene have been generated (Mat-
suyama et al., 1993; Reis et al., 1994) and were shownHans-Willi MittruÈ cker,* Gordon S. Duncan,*
Susi Bischof,² Martin RoÈ llinghoff,² and Tak W. Mak* to be less resistant than normal mice to infection with
encephalomyocarditis virus, but not to infection with*Ontario Cancer Institute
Amgen Research Institute vesicular stomatitis virus (Kimura et al., 1994). This indi-
cates that IRF-1-mediated effects on IFN-inducibleand the Departments of Immunology and
Medical Biophysics genes are responsible for clearance of some, but not
all, viruses.University of Toronto
Toronto, Ontario M5G 2M9 A binding site for IRF-1 has also been detected within
the IL-12 promoter (Ma et al., 1996). This suggests thatCanada
²Institute fuÈ r Klinische Mikrobiologie und IRF-1 may influence the pattern of lymphokines pro-
duced by T helper (Th) lymphocytes, because IL-12 isImmunologie
der UniversitaÈ t Erlangen-NuÈ rnberg considered to be pivotal for the differentiation of these
cells. While antigenic triggering of naive T cells in theWasserturmstr. 3 91054 Erlangen
Federal Republic of Germany presence of IL-12 leads to the appearance of Th1 cells
³School of Veterinary Medicine secreting IL-2 and IFNg, the absence of IL-12 and pres-
Departments of Pathology, Microbiology, ence of IL-4 correlates with the development of Th2
and Immunology cells secreting IL-4, IL-5, IL-6, and IL-10 (Le Gros et al.,
University of California 1990; Swain et al., 1990; Hsieh et al., 1993). However,
Davis, CA 95616 the effect of IRF-1 on the secretion of Th1/Th2 cytokines
has not been examined to date.
One of the best studied models for the induction of
Th1 or Th2 cells in vivo is murine cutaneous Leishmania-Summary
sis, induced by subcutaneous inoculation of the proto-
zoan parasite Leishmania major (L. major). In resistantThe transcription factor interferon regulatory factor-1
mice (e.g., C57BL/6), parasite-specific Th1 cells activate(IRF-1) mediates the effects of IFN. No information
parasite-killing macrophages to contain the infectionexists on its role in lymphokine production. Protection
(reviewed by Reiner and Locksley, 1995). However, inagainst the intracellular pathogen Leishmania major
susceptible mice (e.g., BALB/c), L. major-specific Th2depends on a Th1 response. Here, we show that CD41
T cells from Leishmania-infected mice lacking one cells expand, producing (among other cytokines) IL-10,
(1/2) or both (2/2) alleles of the IRF-1 gene developed which deactivates the macrophages. Visceralization of
a profound, gene dose-dependent decrease in IFNg the disease and development of a high parasite burden
production. IRF-12/2 mice showed dramatically exac- occur, followed by death from the infection.
erbated Leishmaniasis. They produced increased Leish- The difference between the BALB/c and C57BL/6
mania-specific IgG1 and IgE, and their CD41 T cells strains has been a matter of extensive study. Using mice
produced increased IL-4, characteristics of the non- with a transgenic T cell receptor, it has been shown that
protective Th2 response. In cell transfer experiments, the naive Th cells in both strains differ with regard to
IRF-12/2 CD41 T cells mounted normal Th1 responses. the cytokines they produce after their first encounter
However, the ability of IRF-12/2 mice to produce IL-12 with antigen. While Th cells from C57BL/6 mice secrete
was severely compromised. Thus, IRF-1 is a determin- cytokines of Th1 type, BALB/c Th cells are biased to
ing factor for Th1 responses. secrete Th2 type cytokines (Hsieh et al., 1995). It has
been suggested that this behavior results from the rela-
Introduction tive incapability of BALB/c Th cells to respond to IL-12,
and that the gene responsible is located on chromo-
The transcription factor interferon regulatory factor-1 some 11, precisely the chromosome that carries the
(IRF-1) was originally identified as a protein binding to gene for IRF-1 (Gorham et al., 1996). However, a recent
DNA sequences, termed IRF-Es, which are common to report has argued that susceptibility of mice to L. major
the promoters of the IFN a and b genes (Miyamoto et infection is in fact encoded by several genes, some of
al., 1988; Harada et al., 1989). More recently, IRF-1 was which may not be located on chromosome 11 (Demant
reported to bind to the IFN-stimulated regulatory ele- et al., 1996).
ments (ISREs) found in many IFN-inducible gene pro- In the present report, we directly analyze the signifi-
moters, such as those for the p65 double-stranded RNA- cance of the IRF-1 gene in the differentiation of Th cells,
dependent protein kinase, the major histocompatibility using mice of a genetic C57BL/6 background deficient
class I molecules, the 29±59 oligoadenylate synthetase, in one or two alleles of the IRF-1 gene. We infected these
and the inducible nitric oxide synthase (iNOS; Pine et mice with L. major and examined both their resistance to
al., 1990; Reis et al., 1992; Harada et al., 1993; Tanaka infection and their development of Th1/Th2 responses.
et al., 1993; Kamijo et al., 1994). Mice with a targeted We show that deficiency in IRF-1 leads to strongly im-
paired Th1 responses and enhanced Th2 responses in
vivo.§Both authors contributed equally to this paper.
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Figure 1. Cytokine Production by CD41 T
Cells of IRF-11/2 and IRF-12/2 Mice
The proportion of IFNg-(FL1-H, y-axis) and
IL-4-(FL2-H, x-axis) producing LN T cells
(gated on CD41 T cells) from individual Leish-
mania-infected (A) and uninfected (B) wild-
type C57BL/6 (left panels), IRF-1 (1/2) (middle
panels), and IRF-1 (2/2) (right panels) mice.
Mice were infected with 2 3 107 promasti-
gotes. At 4 weeks after infection, right popli-
teal LNs were removed, and LNC were as-
sessed for intracellular cytokine production.
The data are given for two individual mice per
group and are representative of four to five
mice per group and two separate experi-
ments. For infected mice, the mean (%) 6 SD
of positive cells in this experiment were as
follows: IFNg (1/1): 17.5 6 2.0, (1/2): 8.0 6
0.6, and (2/2): 1.3 6 0.6; IL-4 (1/1): 0.5 6
0.2, (1/2): 0.9 6 0.1, and (2/2): 2.4 6 0.3. A
FACS scan of CD41 T cells from L. major-
infected IRF-11/2 mice stained with isotype-
matched control antibodies is also shown.
Results mice (Figure 1A). Similar results were obtained when
IL-10, another Th2 cytokine, was examined (data not
shown). LNC of mice tested 7 weeks after infection gaveDeficiency in IRF-1 Strongly, and in a Gene
Dose-Dependent Manner, Suppresses the comparable results, as did splenic CD41 T cells (data
not shown).Capacity of Mice to Develop Th1 Cells
during Infection with L. major When culture supernatants (SN) of LNC from L. major-
infected mice were tested by ELISA 48 hr after in vitroTo study the role of IRF-1 in the development of Th1
cells in vivo, wild-type (1/1) C57BL/6 mice and IRF-1- restimulation with parasite antigens, the shift to a Th2
response in IRF-12/2 mice was even more striking (Tabledeficient (1/2 or 2/2) mice of C57BL/6 genetic back-
ground were infected subcutaneously with L. major. 1). At both 4 weeks (data not shown) and 7 weeks (Table
1) after infection, the production of IL-4 was elevated,Four weeks later, the lesion-draining popliteal lymph
nodes (LN) were removed, and single cell suspensions
were made. The potential of these LN cells (LNC) to
Table 1. Cytokine Production by Total LNC of IRF-11/2produce lymphokines was analyzed separately for each
and IRF-12/2 Miceindividual mouse, by stimulating thecells for 4 hr with the
Amounts of IL-4 (pg/ml) and IFNg (pg/ml) 6 SD in Culture Superna-polyclonal T cell stimulators phorbol myristate acetate
tants of IRF-11/2 and IRF-12/2 CD41 T(PMA) and ionomycin. Thereafter, the cells were har-
vested and processed for intracellular fluorescence Cytokine IRF-12/2 IRF-11/2
staining of their lymphokines, followed by fluorescence-
mouse 1 mouse 2
activated cell sorter (FACS) analysis (Figure 1).
2LmAg 1LmAg 2LmAg 1LmAgDeficiency in IRF-1 led to a dramatic defect in CD41
IL-4 83 6 12 87 6 13 ,7.5 ,7.5T cell production of IFNg (Figure 1A). This effect was
IFNg ,40 ,40 ,40 1450 6 400
clearly gene dose-dependent, manifested as a two-fold
Amounts of IFNg and IL-4 (mean of four to five individually testedreduction compared with the wild-type in the proportion
mice per group 6 standard deviation, SD) secreted in response toof IFNg-producing CD41 T cells in IRF-11/2 mice, and
L. major-antigens by total popliteal LNC of IRF-12/2 and IRF-11/2
an eight-fold reduction in IRF-12/2 mice. Figure 1B mice were determined 7 weeks after infection with L. major. LNC
shows that LNC of uninfected mice produced equally (2 3 105/well) were cultured with or without an L. major-antigen
low levels of IFNg, regardless of genotype, and that the preparation (``LmAg''; lysates of 3 3 105 promastigotes/well) and
irradiated syngeneic spleen cells from uninfected C57B1/6 micedifferences depicted in Figure 1A were induced during
(3 3 105/well) in 200 ml. After 48 hr, SN were harvested and testedinfection. In contrast, the proportion of IL-4-producing
for IFNg and IL-4 by ELISA. The data are representative of twoCD41 T cells in IRF-12/2 mice was increased three-fold
experiments.
during infection compared with CD41 T cells in IRF-11/2
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Figure 3. Time-Dependent Increase in Lesion Size after L. major
Infection in Wild-Type C57BL/6 (1/1), IRF-11/2, and IRF-12/2 mice
Mice (four to five mice per group) were infected as described for
Figure 1. At the indicated time points, the thickness of the infected
and the contralateral uninfected footpad were measured, and the
increase in footpad thickness (%) was calculated. The bars denote
the SD. The data are representative of three independent experi-
ments.
However, due to their small absolute numbers (Matsu-
yama et al., 1993; data not shown), CD81 T cells in
IRF-12/2 mice did not significantly enhance the deficient
parasite-specific IFNg production of total IRF-12/2 LNC
(Table 1).
During a Th2 response, B cells secretehigher amounts
of IgG1 and IgE, while a Th1 response leads to enhanced
secretion of IgG2a (Snapper and Paul, 1987). To test for
the L. major-specific antibody responses of individual
IRF-12/2 and IRF-11/2 mice, sera from individual mice
were analyzed 7 weeks after infection. As anticipated
from the lymphokine analyzes, a 10-fold increase in the
L. major-specific IgG1-response (Figure 2A) and a 9- toFigure 2. L. major±Specific IgG1, IgG2a,and IgE Levels in Individual
27-fold increase in the IgE response (Figure 2B) wereIRF-12/2 and IRF-11/2 Mice
observed in IRF-12/2 mice compared to IRF-11/2 mice.Mice were infected as described for Figure 1. After 7 weeks, mice
were bled, and sera weretested for the presence of L. major-specific The amount of L. major-specific IgG2a remained un-
antibodies by ELISA. changed, such that the ratio of IgG1 to IgG2a clearly
(A) The data represent the final dilutions of the sera from infected implied a shift toward a Th2 response in IRF-12/2 mice.
mice that reacted positively in the ELISA when compared to a 1:100
dilution of sera from uninfected C57BL/6 mice.
The Th2 Type Immune Response in IRF-1 Deficient(B) The sera described in (A) were diluted as indicated to determine
Mice Is Accompanied by EnhancedL. major-specific IgE-levels. The optical density of a 1:150 dilution
of sera from uninfected C57BL/6 mice was 209. The data are repre- Disease Susceptibility
sentative of two independent experiments. The BALB/c strain, an inbred mouse strain with a partic-
ular bias toward a Th2 typeimmune response, issuscep-
tible to infection with L. major (Reiner and Locksley,
1995), and parasite-specific Th2 cells have been shownand that of IFNg depressed, in LNC from IRF-12/2 mice.
IRF-11/2 total LNC showed the expected increase in to be responsible for this disease pattern (Scott et al.,
1988). To determine whether the shift from a Th1 to aIFNg production in response to exogenous L. major anti-
gens. The exogenous addition of parasite antigens did Th2 response in IRF-1-deficient mice was also accom-
panied by increased susceptibility to infection with L.not further enhance IL-4 production in IRF-12/2 LNC
because the cells already contained saturating amounts major, the course of Leishmaniasis was examined in
wild-type, IRF-11/2, and IRF-12/2 mice. Increase in lesionof endogenous parasite antigens due to the infection
(see below). size (i.e., of the right hind footpad, where the infection
had been introduced) was used to monitor the diseaseOnly CD41 and not CD81 T cells in IRF-12/2 mice
failed to secrete IFNg, since the proportions of IFNg- (Figure 3). Wild-type C57BL/6 mice developed a tempo-
rary swelling of the footpad which healed by week 7. Aproducing CD81 T cells in uninfected, as well as in
L. major-infected, IRF-12/2 mice were considerably defect in one IRF-1 allele (1/2) led to a greater, but
still temporary, increase in footpad-swelling; the lesionsgreater than those in IRF-11/2 mice (data not shown).
Immunity
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Table 2. Parasite Burden in L. major-Infected IRF-11/2 and IRF-12/2 Mice
Cell Number Containing One Leishmania (log)
Number of Weeks Postinfection Lymph Node (IRF-1 Genotype) Spleen (IRF-1 Genotype)
1/1 1/2 2/2 1/1 1/2 2/2
Four 1.5 6 0.1 1.1 6 0.2 21.35 6 0.2 5.7 6 0.4 3.0 6 0.2 1.2 6 0.1
Seven 3.0 6 0.2 2.2 6 0.4 21.72 6 0.1 5.0 6 0.4 3.3 6 0.3 21.0 6 0.2
Parasite burdens in the popliteal LN draining the infected footpad or in the spleen of wild type C57BL/6 (IRF-11/1), IRF-11/2, or IRF-12/2 mice
were assessed 4 and 7 weeks after L. major-infection. Serial dilutions (1:3) of single cell suspensions obtained from individual mice were
transferred into 96-well culture plates (24 wells per dilution). After 10 days, growth of parasites was determined. The dilution containing 37%
negative wells was taken to represent the original plating of a single Leishmania per well. Results are given as the log of the cell number
(mean 6 SD of four to five mice per group) plated per well in this dilution. The data are representative of two separate experiments.
were not completely resolved by the end of the experi- mice were observed (Table 3). Quite surprisingly, no
differences in parasite burden were detected betweenment. In contrast, IRF-12/2 mice developed a strong,
continuous increase in footpad thickness with ulcer- mice of the same genotype infected with different num-
bers of L. major, indicating that, at this early time pointations similar to those seen in BALB/c mice; these mice
had to be euthanized by week 7. At autopsy, only IRF- after infection, the parasite burden was determined
more by the local environment in the LN than by the12/2 mice contained dramatically enlarged spleens (2.7
6 0.4 3 108 cells in IRF-12/2 spleens, compared with infectious dose. However, even though the numbers of
parasites in these LNC from IRF-11/2 and IRF-12/2 mice1.2 6 0.1 3 108 cells in IRF-11/2 spleens), again reminis-
cent of the increase in spleen size observed in L. major- were equal, LNC of IRF-12/2 mice secreted Th2 cyto-
kines and LNC of IRF-11/2 mice produced Th1 cytokines.infected BALB/c mice.
To determine whether increased footpad swelling and Thus, the antigen load was not responsible for the Th2
phenotype of IRF-12/2 mice.enlargement of the spleen reflected a higher systemic
parasite burden in IRF-1-deficient mice, single cell sus-
pensions were prepared from the spleens and lesion- CD41 T Cells of IRF-12/2 Mice Mount a Th1
draining popliteal LN of L. major-infected wild-type, IRF- Response When Transferred
11/2, and IRF-12/2 mice at 4 and 7 weeks after infection. into IRF-11/1 Mice
The cell suspensions were plated in limiting dilutions in The bias toward Th2 responses in IRF-12/2 mice could
microtiterplates (Lima et al., 1985), and the number of be caused by either a primary T cell defect or by a lack
parasites per cell number plated was determined for of signals delivered by an APC that are necessary for
each individual mouse. The representative results of two the differentiation of precursor Thp cells into Th1 cells.
independent experiments are given in Table 2. To differentiate between these two possibilities, CD41
The parasite burdens were inversely related to IFNg T cells from either IRF-11/2 or IRF-12/2 mice were puri-
production. IRF-11/1 wild-type mice with healed local fied and transferred into RAG-1-deficient mice (Mom-
lesions contained small numbers of parasites within LN baerts et al., 1992), which lack T and B cells, but which
and spleens at both time points, consistent with a previ- contain two wild-type IRF-1 alleles. In order to compen-
ous report (Stenger et al., 1996). However, deficiency of sate for the lack of B cells in RAG-12/2 mice, B cells
one or both IRF-1 alleles led to a gene dose-dependent
increase in the parasite burden in the lesion-draining
lymph nodes, as well as in the spleens. Seven weeks
after infection, spleens of IRF-12/2 mice contained 106
times more parasites than the spleens of control
IRF-11/1 wild-type mice.
The Shift to Th2 in IRF-12/2 Mice Is Not
Caused by the High Parasite Load
It has been shown that the dose of antigen can have an
important impact on the Th phenotype of an immune
response: intermediate antigen concentrations lead to
Th1 responses, while high antigen loads provoke Th2
responses (Constant et al., 1995; Hosken et al., 1995).
To rule out that the switch to Th2 in IRF-12/2 mice was
simply a matter of their high parasite burden, IRF-11/2
and IRF-12/2 mice were infected with a high and a low
Figure 4. Time-Dependent Increase in Lesion Size after L. majornumber of L. major parasites, and their Th responses
Infection in Reconstituted RAG-12/2 Mice
were examined. One week after infection, the mice were
RAG-1-deficient mice (three mice per group) were left untreated orsacrificed, the popliteal LNs were removed, and single
injected intraperitoneally with B cells from IRF1/1 mice with or with-
cell suspensions were tested for L. major-specific cyto- out CD41 T cells from IRF1/2 or IRF2/2 mice. All mice were then
kine production,as well as for parasite burden. No differ- infected on the same day with L. major, and the lesion size was
monitored as described for Figure 3.ences in parasite burden between IRF-11/2 and IRF-12/2
IRF-1 Is Required for Th1 Response In Vivo
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Table 3. Cytokine Production and Parasite Burden in IRF-11/2 and IRF-12/2 Mice in Response to High and Low Antigen Loads
IRF-12/2 IRF-11/2
Number of Promastigotes Injected 5 3 105 1.5 3 106 5 3 105 1.5 3 106
Parasite Burden 2.8 6 0.3 2.5 6 0.3 3.2 6 0.1 2.3 6 0.3
IFNg (pg/ml) ,40 80 750 2250
IL-4 (pg/ml) 135 230 125 55
IRF-12/2 and 1/2 mice (three mice per group) were infected with the indicated numbers of L. major promastigotes, as described for Figure 1.
One week later, mice were killed, and the popliteal LNC of individual mice were tested for parasite burden, as described for Table 2. As for
Table 2, the results are given as the log of the cell number (mean 6 SD of three mice per group) containing one Leishmania. Pooled LNC of
the different groups of mice were also tested for L. major-specific cytokine production, as described for Table 1. Only results obtained in the
presence of LmAg are depicted, because, in the absence of LmAg, all cytokine quantities were below the level of sensitivity of the ELISA.
The data are representative of two separate experiments.
from IRF-11/1 wild-type mice were cotransferred. The promastigotes. One week later, the lesion-draining LN
were removed, the LNC were stimulated with LPS inreconstituted mice were infected with L. major, and the
course of disease was monitored (Figure 4). In the ab- vitro, and the SN were tested for the presence of IL-12
after 48 hr. The results of two experiments are given insence of reconstitution, RAG-12/2 mice developed a
strong, continuous increase in footpad thickness, as Table 5. In LNC of IRF-11/2 mice, IL-12 production was
inducible by LPS, provided that the mice had been in-expected for a T cell-deficient mouse. Transfer of IRF-
11/1 wild-type B cells alone did not change this course fected with L. major. LNC of IRF-12/2 mice, whether or
not they had been infected with L. major, produced noof disease. In contrast, RAG-12/2 mice reconstituted
with B cells as well as with CD41 T cells from either IRF- IL-12. Similar results were obtained when spleen cells
were analyzed (data not shown). The defect was specific11/2 or IRF-12/2 mice showed only the mild increase in
footpad thickness commonly observed in resistant for IL-12, because there was no difference in LPS-
induced TNFa production (e.g., IRF-12/2, 530 pg/ml; IRF-mice. Similarly, the parasite burden was equally low in
mice reconstituted with CD41 T cells from either IRF- 11/2, 420 pg/ml) between LNC isolated from IRF-11/2
and IRF-12/2 mice infected with 1.5 3 106 promastigotes.11/2 or IRF-12/2 mice (Table 4). In contrast, in the ab-
sence of reconstitution or after transfer of B cells alone, In addition, the defective production of IL-12 in IRF-12/2
LNC could not be attributed to reduced numbers ofRAG-12/2 mice contained high numbers of parasites. In
vitro, LNC of RAG-12/2 mice produced a Th1 pattern of macrophages, because the frequency of cells carrying
the macrophage marker F4/80 was slightly enhanced incytokines in response to L. major antigens, regardless
of whether they had been reconstituted with CD41 T IRF-12/2 LNC compared with IRF-11/2 LNC (data not
shown). Thus, a lack of functional IRF-1 appears to pre-cells from either IRF-11/2 or IRF-12/2 mice. No detect-
able cytokines were produced by LNC of RAG-12/2 mice vent the secretion of IL-12 in response to L. major infec-
tion, a circumstance that could explain the bias of IRF-that had received either no cells or only B cells. Taken
together, these data clearly show that CD41 T cells from 12/2 mice to the Th2 phenotype.
IRF-12/2 mice are, in principle, able to mount a Th1
response, provided that they are stimulated in the pres- Discussion
ence of competent APC.
In this study, we demonstrate that lack of IRF-1 strongly
blocks the mounting of a Th1 response. LN T cells ofDeficient IL-12 Production in IRF-12/2 Mice
The presence of an IRF-1 binding site in the promoter IRF-12/2 mice produced 30 times less IFNg in response
to antigens of the protozoan parasite L. major than didof the IL-12 gene (Ma et al., 1996) raised the possibility
that defective IL-12 secretion was the primary cause of T cells of IRF-11/2 mice, a result replicated when the
same LN T cells were analyzed at the single cell levelthe shift toward Th2. To test this hypothesis, IRF-11/2
or IRF-12/2 mice were either left untreated or were in- for intracellular cytokines produced in response to poly-
clonal stimulation. Here, a clear gene dose effect couldfected in their footpadswith high or low doses of L. major
Table 4. Cytokine Production and Parasite Burden in L. major-Infected RAG-1-Deficient Mice Reconstituted with IRF-11/2 or IRF-12/
2 CD41 T Cells
Transferred Ð B cells B cells B cells
Cells Ð Ð IRF-12/2 CD41 IRF-11/2 CD41
Parasite Burden 0.6 6 0.0 1.4 6 0.5 4.6 6 1.1 5.1 6 0.9
In Vitro Stimulus 1LmAg 2LmAg 1LmAg 2LmAg 1LmAg 2LmAg 1LmAg 2LmAg
IFNg (pg/ml) ,40 ,40 ,40 ,40 3200 80 4800 140
IL-4 (pg/ml) ,7.5 ,7.5 ,7.5 ,7.5 200 ,7.5 190 ,7.5
RAG-12/2 mice (3 mice per group) were either left untreated or were injected i.p. with IRF-11/1 B cells (11 3 106/mouse) with or without CD41
T cells of either IRF-12/2 or 1/2 genotype (7 3 106/mouse), as indicated. After cell transfer, all mice were infected with promastigotes, as
described for Figure 1. Five weeks later, the mice were killed. The parasite burdens in the spleens of individual mice were measured, as
described for Table 2, and are given as the cell number containing one leishmania (mean log 6 SD). The lesion-draining LNC of each group
were pooled and restimulated in vitro to determine cytokine production, as described for Table 1.
Immunity
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Table 5. IL-12 Production in LNC of IRF-11/2 and IRF-12/2 Mice
Amount of IL-12 (p70) Produced (pg/ml)
Experiment 1 Experiment 2
0 5 3 105 1.5 3 106 0 1.5 3 106
Number of Promastigotes Injected
Mouse Genotype (IRF-1) 2/2 1/2 2/2 1/2 2/2 1/2 2/2 1/2 2/2 1/2
1LPS ,1 ,1 ,1 21.5 ,1 44.9 ,1 ,1 ,1 21.7
2LPS ,1 ,1 ,1 ,1 ,1 ,1 ,1 ,1 ,1 ,1
IRF-12/2 and IRF-11/2 mice (three mice per group) were infected with the indicated numbers of L. major promastigotes as described for Figure
1. One week later, the mice were killed, and the popliteal LNC were cultured (8 3 105/200 ml) in the presence or absence of LPS (10 mg/ml),
as indicated. 48 hr later, the SN were harvested, and an IL-12 capture bioassay with a sensitivity of 1 pg/ml was performed, as described in
the Experimental Procedures.
be observed, since the proportion of CD41 T cells pro- by a double-hit effect: the production of both IFNg and
iNOS are decreased in the absence of IRF-1, leading toducing IFNg was reduced two-fold (compared to wild
type) in IRF-11/2 mice and eight-fold in IRF-12/2 mice. decreased macrophage activation and reduced killing
power.This difference was observed only in infected mice,
since IFNg production was equally low in uninfected How does a lack of IRF-1 at the molecular level lead
to suppressed Th1 and enhanced Th2 responses? It ismice of all IRF-1 genotypes. In addition, the defect in
IFNg production was restricted to CD41, and not CD81, unlikely that IRF-1 directly affects transcription of the
IFNg gene, because no binding site for IRF-1 has beenT cells.
The lack of Th1 response in IRF-12/2 mice was associ- reported in the promoter of the IFNg gene and because
IFNg production was in fact enhanced in IRF-12/2 CD81ated with an enhanced Th2 response, characterized by
increases in IL-4 and IL-10 production (not shown) T cells. This suggests that the effects of IRF-1 are medi-
ated through other genes, which in turn influence thefollowing antigen-specific as well as polyclonal stimula-
tion. The antibody response was also of Th2 type (Snap- transcription of the IFNg gene.
IRF-1 probably does not influence Th1 developmentper and Paul, 1987), since higher levels of L. major-
specific IgG1 and IgE antibodies were raised in IRF-12/2 by acting on the CD41 T cell itself. In RAG-12/2 (IRF-
11/1) mice, the IRF-12/2 CD41 T cells were just as ablemice than in IRF-11/2 mice. This phenotype was also
obvious only after infection with L. major, since the total to develop into Th1 cells as were IRF-11/2 CD41 T cells,
and L. major infections were readily contained. This re-levels of IgG1 and IgE were similar in uninfected IRF-
12/2 and IRF-11/2 mice. These results show that B cells sult suggests that the APC is responsible for the Th2
phenotype in IRF-12/2 mice.in IRF-12/2 mice do not intrinsically produce more Th2
type antibodies. APC are known to influence the development of Th1
cells in two ways: by the amount of antigen presented,The shift in Th phenotype in mice deficient in one
or two alleles of the IRF-1 gene adds important new and by the secretion of IL-12. High and low concentra-
tions of antigen have been shown to favor the develop-information about the function of this transcription fac-
tor. So far, IRF-1 is known to be very important in the ment of Th2 cells, whereas intermediate concentrations
of antigen presented by the same APC were found toresponse of cells to IFN, as well as for the production
of type I interferons (Miyamoto et al., 1988; Harada et trigger Th1 development (Constant et al., 1995; Hosken
et al., 1995). However, it is unlikely that the bias for Th2al., 1989; Pine et al., 1990; Reis et al., 1992; Harada
et al., 1993; Tanaka et al., 1993; Kamijo et al., 1994). response observed in IRF-12/2 mice merely reflects an
effect of the antigen load. This conclusion is derivedConsistent with these roles, IRF-1 has been shown to
be necessary for the clearance of some (but surprisingly, from the situation where parasite antigen loads were
equal in L. major-infected IRF-12/2 and IRF-11/2 mice,not all) viral infections by CD81 T cells (Kimura et al.,
1994). Our study has shown that this transcription factor but cytokines of Th2 type were nevertheless produced
by IRF-12/2 CD41 T cells, and of Th1 type by IRF-11/2is also involved in the Th1/Th2 differentiation decision,
and that the bias to Th2 in L. major-infected IRF-12/2 CD41 T cells. This led us to examine IL-12 production
in APC and, indeed, using two stimuli known to triggermice has important functional consequences for theout-
come of a parasitic infection, which normally is healed IL-12 production in macrophages (Reiner et al., 1994;
van der Pouw Kraan et al., 1995), LPS and amastigoteswith the help of Th1 cells.
It has been shown convincingly that a principal path- (the L. major parasite form of the infected tissue), we
identified a profound defect in IL-12 production by le-way of Leishmania clearance is mediated by IFNg pro-
duced by Th1 cells (Wang et al., 1994; Swihart et al., sion-draining LN of IRF-12/2 mice. Lack of secretion
of IL-12 by APC could be the primary reason for Th21995). IFNg activates macrophages, the host cells of
Leishmania, to kill the parasites by (among other meth- development and disease susceptibility in IRF-12/2
mice. This hypothesis is consistent with earlier reportsods) production of NO (Green et al., 1991). In addition,
a binding site for IRF-1 has been identified in the pro- that showed that mice of a resistant genotype exhibited
the Th2 phenotype and more severe disease after treat-moter of the iNOS gene, and a lack of IRF-1 has been
shown to strongly affect the amount of iNOS produced ment with anti-IL-12 (Scharton et al., 1995).
Finally, we would like to discuss our results in the(Kamijo et al., 1994). The exquisite susceptibility of IRF-
12/2 mice to infection with L. major can thus beexplained context of a recent study by Gorham et al. (1996) that
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of the wells were negative for parasite growth was taken to representmapped a gene responsible for Th development to chro-
the original plating of one single Leishmania.mosome 11, precisely the chromosome upon which the
IRF-1 gene is located. This gene has yet to be identified,
Intracellular Staining of Cytokinesbut it is known to be responsible for Th1 development
At 4 and 7 weeks after infection of the mice with L. major, rightin C57BL/6 mice and for Th2 development in BALB/c
popliteal LNs were removed, single cell suspensions were made,
mice. On this basis, this gene has been proposed as a and LNC of individual mice were cultured for 4 hr in 10 mg/ml of
candidate gene responsible for resistance/susceptibility brefeldin A plus 10 ng/ml of PMA and 500 ng/ml of Ionomycin.
in murine Leishmaniasis (Gorham et al., 1996). The ques- For control uninfected mice, the two popliteal and inguinal LNs of
individual mice were pooled. The cells were removed from culturetion arises as to whether the IRF-1 gene may be this
and assessed for intracellular cytokine production as previouslyunknown gene. However, other recent evidence has
described (Ferrick et al., 1995; Hsieh et al., 1996). Lymphokines weresuggested that susceptibility to L. major infection is
identified using an anti-mouse IFNg antibody directly conjugated tomultifactorial (Demant et al., 1996), although a gene lo-
FITC (Caltag Lab., San Francisco, CA), an anti-mouse IL-4 antibody
cated on chromosome 11 may still be involved. Gorham directly conjugated to PE (Caltag), and anti-mouse CD4 and CD8
et al. reasoned that the candidate gene leads to reduced antibodies directly conjugated to Tri-color (Caltag). The samples
IL-12 responsiveness of BALB/c Th cells in vitro. Inter- were run on a FACScan and analyzed using the Cell Quest software.
estingly, however, such reduced IL-12 responsiveness
only became apparent after repeated restimulation in Determination of Cytokines by ELISA
The same LNC that were tested for intracellular cytokines were alsovitro, which could be explained by earlier results that
restimulated (2 3 105/well) in vitro with uninfected, irradiated (20Gy)showed that differentiated Th2 cells lack respon-
syngeneic spleen cells (3 3 105/well), with or without L. major anti-siveness to IL-12 (Szabo et al., 1995). Reduced respon-
gens (ªLmAgº; freeze-thawed lysates of 3 3 105 promastigotes/siveness to IL-12 in BALB/c Th cells leading to enhanced
well), in a total volume of 200 ml in microtiterplates (Nunc, Roskilde,
Th2 differentiation (Gorham et al., 1996) may therefore Denmark). After 48 hr, culture supernatants (SN) were harvested
be only secondary to a different primary defect, e.g., in and tested for IL-4 and IFNg using commercial ELISAs (Pharmingen,
IL-12 production, such as would occur in the absence San Diego). The values measured werestandardized against recom-
binant IL-4 and IFNg.of IRF-1. Reduced IL-12 production in BALB/c mice has
already been reported (Gieni et al., 1996).
Determination of L. major-Specific Antibodies in SerumWe also tested for IL-12 responsiveness of CD41 T
Mice were infected with 2 3 107 stationary-phase L. major promasti-cells from uninfected IRF-12/2 and IRF-11/2 mice. Using
gotes. After 7 weeks, mice were bled, and sera were tested for theintracellular staining of IFNg, after overnight stimulation
levels of L. major-specific IgG1, IgG2a, and IgE using an ELISA, as
with PMA and Ionomycin in the presence or absence of described (Hoerauf et al., 1994). Isotype-specific visualization of
IL-12, we found that IL-12 responsiveness was substan- the ELISA was accomplished using a kit purchased from Southern
tially reduced in IRF-12/2 CD41 T cells compared with Biotechnology (Birmingham, AL).
IRF-11/2 CD4 T cells (0.5% versus 5% responders, re-
spectively, of total CD41 T cell blasts). However, since Cell Transfer Experiments
Male RAG-1-deficient mice (Mombaerts et al., 1992) bred back towe have shown in our cell transfer experiments that IRF-
C57BL/6 for five generations were obtained from Taconic (German-12/2 CD41 T cells are perfectly capable of differentiating
town, NY). Male C57BL/6 mice were purchased from Jackson andinto Th1 cells, we argue that the lack of IL-12 respon-
used at 8 weeks of age. Single cell suspensions obtained from thesiveness in IRF-12/2 CD41 T cells is secondary to re-
spleens of C57BL/6 mice were depleted of CD41, CD81 and Thy1.21
duced IL-12 production by APC with a primary defect cells using the MACS-system (Miltenyi, Bergisch Gladbach, Ger-
in IRF-1. many). The antibodies directed against these markers were conju-
gated to magnetic beads (Miltenyi). Cell purification was performed
Experimental Procedures according to the manufacturer's recommendations (Miltenyi et al.,
1990). The resulting cell population, referred to in the study as ªB
IRF-1-Deficient Mice cells,º contained 95% B2201 cells.
The IRF-11/2 and IRF-12/2 mice used in this study were of the sixth To obtain purified CD41 cells, spleens and LNs from either male
backcross generation to C57BL/6 (obtained from Jackson Labora- IRF-11/2 or male IRF-12/2 mice were pooled. Single cell suspensions
tories, Bar Harbor, ME). were obtained and depleted of CD81, B2201, and MAC-11 cells
using antibodies conjugated to magnetic beads and the MACS sys-
Infection of Mice with L. major and Monitoring of the Disease tem, as described above. The resulting cell population consisted of
Unless otherwise indicated, mice were injected in the right hind .95% (IRF-12/2) and .92% (IRF-11/2) CD41 cells. Contamination
footpad with 2 3 107 stationary-phase promastigotes of the L. major with CD81 or B2201 cells was always below 1%. RAG-1-deficient
strain MHOM/IL/81/FEBNI (Stenger et al., 1996) in 50 ml buffer. mice were reconstituted with 11 3 106 B cells with or without 7 3
Thereafter, the thickness of the infected and the contralateral unin- 106 CD41 cells of either IRF-11/2 or IRF-12/2 genotype, and were
fected footpad were measured once per week using a vernier caliper injected in the right hind footpad with 2 3 107 L. major promastigotes
(Kroeplin, SchluÈ chtern, Germany). The increase in footpad thickness in 50 ml buffer on the same day. Five weeks after cell transfer,
(%) was calculated according to the formula: ([thickness of infected mice were killed and cytokine production and parasite burden were
footpad 2 thickness of uninfected footpad]/[thickness of uninfected determined as described above.
footpad]) 3 100.
For determination of the parasite burden, mice were killed, LN
IL-12 Assayand spleens were removed, and serial dilutions (1:3) of single cell
Mice (three per group) were left untreated or were infected in theirsuspensions obtained from individual mice were pipetted into 96-
right hind footpads with various amounts of L. major promastigotes.well flat-bottomed culture plates (24 wells per dilution), in medium
One week later, the lesion-draining popliteal LN were removed, andmade up according to a published formula (Lima et al., 1985). The
single cell supensions were restimulated (8 3 105/well) with LPSplating efficiency in this medium was between 85% and 95%, as
(serotype 0111 B4, Sigma; 10 mg/ml) in 200 ml medium in 96-welldetermined by culture of counted numbers of L. major promasti-
tissue culture plates (Nunc) for 48 hr. For determination of IL-12 ingotes. After 10 days, growth of parasites was determined macro-
culture SN, a capture bioassay (Wysocka et al., 1995) was per-scopically and microscopically. In accordance with Poisson statis-
tics (Lefkovits and Waldmann, 1984), the cell dilution in which 37% formed. The protocol for this assay was established by T. Germann,
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University of Mainz, Germany, and will be published in detail else- Hsieh, C.S., Macatonia, S.E., O'Garra, A., and Murphy, K.M. (1995).
T cell genetic background determines default T helper phenotypewhere (D. Laubert, E. RuÈ de, and T. Germann, unpublished data).
development in vitro. J. Exp. Med. 181, 713±721.Briefly, 96-well tissue culture plates (Nunc) were coated with anti-
p53 mAb RedT/G297±289 (Pharmacia) at 8 mg/ml and incubated Hsieh, B., Schrenzel, M.D., Mulvania, T., Lepper, H.D., DiMolfetto-
with the IL-12-containing samples, or with a standard dilution of Landon, K., and Ferrick, D.A. (1996). In vivo cytokine production in
recombinant murine IL-12 (Pharmingen), as recommended for the murine listeriosis: evidence for immunoregulation by gd1 T cells. J.
IL-12 ELISA by the manufacturer. After washing, bound IL-12 was Immunol. 156, 232±237.
used to stimulate F7.15A cells (Gradehandt et al., 1988; 1 3 105/ Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J.,
well) in the presence of 1 ng/ml IL-2 in a total volume of 100 ml for Shapiro, D., Le, J., Koh, S.I., Kimura, T., Green, S.J., Mak, T.W.,
48 hr. Thereafter, SN were harvested and tested in the IFNg ELISA. Taniguchi, T., and Vilcek, J. (1994). Requirement for transcription
Under these conditions, the IL-12 assay reproducibly detected as factor IRF-1 in NO synthase induction in macrophages. Science 263,
little as 1 pg/ml of IL-12. 1612±1615.
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